CARRIE SMITH COX
CIK 1110753 · Executive Chair · last filed 2026-05-18
CARRIE SMITH COX is an Executive Chair who has filed 119 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for SOLV, was dated May 18, 2026. Across all open-market trades the lifetime net is −$47.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.2M across reported positions. 20 SEC filings were submitted jointly with CELGENE CORP /DE/.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.20M
10
119
-$47.29M
Filer Profile
2000 GALLOPING HILL ROAD
KENILWORTH, NJ 07033
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLV | Director | 16,400 | $91.69 | $1.50M | $0 | 6 | 2026-05-18 |
| TXN | Director | 46,464 | $258.44 | $12.01M | -$17.25M | 42 | 2026-05-14 |
| OGN | Executive Chair | 90,338 | $13.78 | $1.24M | $602.3K | 7 | 2025-11-13 |
| RNAC | Director | 15,629 | $9.27 | $144.9K | $0 | 3 | 2025-01-06 |
| Cartesian Therapeutics, Inc. (SELB) Delisted | Director | 212,881 | $0.88 | $187.6K | $200.5K | 8 | 2023-01-04 |
| CAH | Director | 41,631 | $247.18 | $10.29M | $20.1K | 15 | 2022-11-10 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | -$2.96M | 16 | 2019-11-22 |
| ECOR | Director | 1,401 | $9.21 | $12.9K | $118.7K | 4 | 2019-06-11 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 1,130 | — | — | $29.5K | 3 | 2010-06-18 |
| MRK | Executive Vice President | 0 | $150.33 | $0 | -$28.06M | 8 | 2009-11-04 |
Recent Filings
119 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | SOLV | Grant (A) | — | $0 | EDGAR |
| 2026-05-14 | TXN | Mixed | — | -$1.76M | EDGAR |
| 2026-05-13 | TXN | Notice (144) | −8,838 | -$2.71M | EDGAR |
| 2026-05-01 | SOLV | Exer (M) | +4,916 | $0 | EDGAR |
| 2026-03-30 | SOLV | Exer (M) | +6,336 | $0 | EDGAR |
| 2026-02-02 | TXN | Grant (A) | +525 | $0 | EDGAR |
| 2025-11-13 | OGN | Buy (P) | +65,400 | $501.8K | EDGAR |
| 2025-06-16 | OGN | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | OGN | Buy (P) | +12,469 | $100.6K | EDGAR |
| 2025-05-15 | SOLV | Exer (M) | +5,148 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.